As of 3:59pm ET
| -0.05 / -0.40%|
The 7 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 22.00, with a high estimate of 26.00 and a low estimate of 17.00. The median estimate represents a +76.71% increase from the last price of 12.45.
The current consensus among 7 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.